A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 44
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LATAM
Long Form : Latin America
No. Year Title Co-occurring Abbreviation
2020 Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study. aONL, NMOSD, ON
2020 Adverse Events and Discontinuation Rates Associated with Sirolimus Treatment in Adult Renal Transplant Patients in Latin America vs Non-Latin American Countries. EU/ROW, NA, SAEs, TEAEs
2020 Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America. APAC, E-EUR, W-EUR
2020 Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients. DMTs, MS, PwMS
2020 Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. CT, MRI, MS, PBVL, T2LV
2020 Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort. ATM, CNS, EDSS, IIF, LETM, MRI, MS, NMOSD, ON
2020 Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort. EDSS, LO-NMOSD
2020 Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure. VREfm
2020 Highlights of an Expert Advisory Board on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) in Latin America. AECOPD, AECOPD, COPD
10  2020 Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study. anti-TNF, APAC, CD, IBD, NICs, RME, UC
11  2020 Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice. NMOSD
12  2020 Pharmaceuticals as emerging contaminants in the aquatic environment of Latin America: a review. PhACs, SW, TWW, WW
13  2020 Prostate Cancer in Latin America: Challenges and Recommendations. AHF, nmCRPC, PCa
14  2020 Registration pathways to accelerate regulatory assessment of innovative medicines in Latin America. CPP
15  2019 A review on the occurrence of companion vector-borne diseases in pet animals in Latin America. CVBDs
16  2019 Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016). APAC, EUR, MDR, NA, XDR
17  2019 AOSpine Global Survey: International Trends in Utilization of Magnetic Resonance Imaging/Computed Tomography for Spinal Trauma and Spinal Cord Injury across AO Regions. APAC, CT, EU, iSCI, MEA, MRI, NA, OR, SCI
18  2019 Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources. HTAi
19  2019 Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America. ABSSSIs, APAC, BHS, CA, E-EUR, MRSA
20  2019 Latin America intensive care unit disaster preparedness: Results from a web-based attitudes and perceptions survey. CI, ICUs, OR
21  2019 Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America. ---
22  2019 Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016. APAC, EFM, NA, UTIs, VRE
23  2019 The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directions. ---
24  2019 Vaccination herd effect experience in Latin America: a systematic literature review. Hib, PCV, VHL
25  2018 A systematic review about the epidemiology of primary progressive multiple sclerosis in Latin America and the Caribbean. MS, PPMS
26  2018 Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America. APAC, CABP, E-EUR, EUR, W-EUR
27  2018 Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America. PPMS, RRMS
28  2018 Edoxaban Versus Warfarin in LatinAmerican Patients With AtrialFibrillation: The ENGAGE AF-TIMI 48 Trial. CI, HR, HR, HR, ICH, nLAS
29  2018 Emerging Infectious Agents and Blood Safety in Latin America. HIV
30  2018 Insulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data. ITQ, T1DM
31  2018 The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. ---
32  2018 Trends in pelvic organ prolapse management in Latin America. POP
33  2017 Access and barriers to MS care in Latin America. CNBD, DMTs, MS
34  2017 Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations. APAC, BJI, MRSA, US
35  2017 Application of the McDonald criteria in Latin America. CNS, MS
36  2017 Epidemiology of neuromyelitis optica in Latin America. MS, NMO, SA
37  2017 Multiple sclerosis epidemiology in Latin America: An updated survey. ---
38  2017 Multiple Sclerosis in Latin Americans: Genetic Aspects. AIMs, GWAS, LA, MS
39  2016 Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations. AK, C-PDT, DL-PDT, MAL
40  2016 Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America. ACB, MIC
41  2015 Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems. HTA, PROs
42  2014 Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011). APAC, EMR, ESBL, USA, UTI
43  2013 Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). ACB, AMK, ARG, BRA, C/S, CBA, COL, EC, ECU, GUA, KSP, LZD, Mex, PAN, PSA, Spn, TIG, VAN, VEN
44  2008 MS in Latin America. MS